SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as Dr. Patrick Soon-Shiong's recent high-profile media appearances sparked widespread discussion about the company's Anktiva cancer treatment, with the community enthusiastically highlighting its potential across all cancer types and for longevity while expressing frustration with perceived regulatory hurdles.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is rocketing higher after exceeding Q4 earnings expectations and providing strong Q1 guidance, fueled by robust demand from hyperscale data centers for its 800G and 400G optical transceivers, with the community now debating explosive growth potential and short squeeze mechanics despite recent dilution concerns.

The Goldman Sachs Group, Inc. engages in the provision of financial services. It operates through the following business segments: Global Banking and Markets, Asset and Wealth Management, and Platform Solutions. The Global Banking and Markets segment includes investment banking, global investments, and equity and debt investments. The Asset and Wealth Management segment relates to the direct-to-consumer banking business which includes lending, deposit-taking, and investing. The Platform Solutions segment includes consumer platforms such as partnerships offering credit cards and point-of-sale financing, and transaction banking. The company was founded by Marcus Goldman in 1869 and is headquartered in New York, NY.

Goldman Sachs Group, Inc.

Goldman Sachs is a key talking point following a strong quarterly earnings beat and a dividend increase, which highlight its resilient investment banking and trading performance amidst broader financial sector headwinds; however, recent legal developments involving its top lawyer are also actively discussed.

The GEO Group, Inc. engages in the design, financing, development, and support services for secure facilities, processing centers, and community re-entry facilities. It operates through the following segments: U.S. Secure, Electronic Monitoring and Supervision, Reentry, and International Services. The U.S. Secure Services segment encompasses the United States-based public-private partnership corrections and detention business. The Electronic Monitoring and Supervision Services segment conducts its services in the U.S. The Reentry Services Segment consists of various community-based and reentry services. The International Services segment consists of public-private partnership secure services operations in Australia and South Africa. The company was founded by George C. Zoley in 1984 and is headquartered in Boca Raton, FL.

Geo Group, Inc.

GEO Group is trending as investors weigh potential massive government contracts, including a recent "skip tracing" deal and inclusion in a $38 billion ICE detention overhaul plan, against recent volatility driven by conflicting reports and community claims of short manipulation amidst strong fundamentals.

Aardvark Therapeutics, Inc. operates as a biotechnology company. It engages in the development of a novel, small-molecule therapeutics for the treatment of metabolic diseases. The company was founded by Tien Lee in 2017 and is headquartered in San Diego, CA.

Aardvark Therapeutics Inc.

Aardvark Therapeutics Inc

Aardvark Therapeutics (AARD) is seeing significant discussion as its Phase 3 HERO trial for ARD-101 in Prader-Willi Syndrome was voluntarily paused due to cardiac safety signals observed at high doses. This unexpected halt is generating widespread community discussion about the future of its lead program and its competitive position against other Prader-Willi Syndrome treatments.

Oddity Tech Ltd. engages in the online retail sale of cosmetics and beauty products. Its products include lipsticks, makeup brushes, mascara, eyelash curlers, and makeup brush cleansers. The company was founded by Oran Holtzman and Shiran Holtzman-Erel on March 23, 2013 and is headquartered in Tel Aviv, Israel.

ODDITY Tech Ltd. - Ordinary Shares - Class A

Oddity Tech is trending after a massive stock drop and a significantly lowered Q1 revenue outlook, attributed to an advertising partner's algorithm change that increased customer acquisition costs, despite strong prior earnings. The community is sharply divided, with many believing the stock is oversold and trading at an incredibly low valuation, while others express deep concern over management's perceived lack of clarity and numerous analyst downgrades.

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.

Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals is trending following its recent FDA approval for Revuforj in NPM1-mutated AML and being named "Best New Drug" at the Scrip Awards. The community is actively discussing the company's significant undervaluation compared to peers and strong M&A potential, particularly with partner Incyte, as investors anticipate upcoming data presentations at major conferences.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as its community anticipates the upcoming 4/20 event, rallying around its identity as a 'culture coin' built for long-term growth and aiming to provide decentralized payment solutions for the global cannabis ecosystem.

Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities with related general business planning, including raising capital. It engages in the discovery of therapies designed to treat immune-mediated diseases. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.

Aldeyra Therapeutics Inc

Aldeyra Therapeutics is actively debated after the FDA extended its reproxalap PDUFA date to March 2026, requesting additional field trial data. While optimists cite ongoing positive label discussions and management confidence, many critics fear a third Complete Response Letter given prior trial failures, a recent executive resignation, and limited cash runway revealed in unexpected earnings.

Dash (DASH) is digital cash designed to offer financial freedom to everyone. Payments are instant, easy and secure, with near-zero fees. Built to support real life use cases, Dash is the leading decentralized payment solution. Users can purchase goods at thousands of merchants and trade it at major exchanges and brokers around the globe. Since its creation in 2014, Dash has demonstrated leadership in innovation and pioneered groundbreaking features such as: -Two-tier network with incentivized nodes and decentralized project governance (Masternodes) -Instantly settled payments (InstantSend) -Instantly immutable blockchain (ChainLocks) -Optional privacy (PrivateSend)

Dash

Dash (DASH CRYPTO) is generating significant buzz following rumored collaborations with POL and recent integration with ACH, leading the community to anticipate a major breakout. As an "OG privacy coin" with scarce supply, investors are actively watching for Dash to follow the strong upward movement seen in Zcash amidst a broader resurgence of interest in privacy tokens.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nirman Agri Genetics Ltd. engages in the research and development, production, and distribution of vegetable seeds. It focuses on developing hybrid in different crop such as corn, cotton, sunflower, paddy, and bajra. It also offers t bio-pesticides, bio-fertilizers, micronutrients, fertilizer mixtures, and plant growth regulators under the name Nirman Agri Genetics. The company was founded on August 19, 2020 and is headquartered in Nashik, India.

NIRMAN.NSE
Nirman Agri Genetics Ltd.

Feed

News

Sentiment

Fundamentals

Info

Latest NIRMAN.NSE News

NIRMAN.NSENirman Agri Genetics Ltd.